Medicine & Healthcare Veterinary medicine

A combination of radiotherapy followed by immunotherapy is a promising strategy for the treatment of oral malignant melanomas in dogs.

Osaka Metropolitan University scientists investigated the prevalence of antimicrobial resistant bacteria in 678 bacterial isolates from 428 companion dogs and 74 companion cats at the Veterinary Medical Center, Osaka Metropolitan University. Two E. coli strains have both a mobile colistin-resistant mcr gene and a third-generation cephalosporin-resistant blaCTX gene. One of these strains, which is found in a dog, was resistant to both colistin and third-generation cephalosporins.

Researchers at Hokkaido University have revealed the effects of high pathogenicity avian influenza virus infection on an Ezo red fox and a Japanese raccoon dog, linking their infection to a recorded die-off of crows.

A research group led by Osaka Metropolitan University and Panasonic Corporation Living Appliances and Solutions Company discovered how nano-sized electrostatic atomized water particles disinfect SARS-CoV-2. The nano-sized electrostatic atomized water particles developed by Panasonic Corporation have an electron rich nano-sized water shell that contains reactive oxygen species. The researchers showed that the water particles damage the viral envelope, protein, and RNA. They also revealed that the damaged virus did not bind to host cells. These phenomena are considered the main inactivation mechanism of the nano-sized electrostatic atomized water particles on SARS-CoV-2.

Whale and dolphin post-mortem imaging could breathe new life into marine conservation.

Scientists have shown that the biological molecule PD-L1 is a potential target for the treatment of metastasized oral malignant melanoma in dogs.

West Nile virus (WNV) inhibits autophagy — an essential system that digests or removes cellular constituents such as proteins — to induce the aggregation of proteins in infected cells, triggering cell death and brain inflammation (encephalitis), according to Hokkaido University researchers.

Scientists have succeeded in reducing levels of the bovine leukemia virus (BLV) in cows with severe infections by combining an immune checkpoint inhibitor and an enzyme inhibitor. The finding could be utilized to control other diseases in cattle, and perhaps in humans someday.